Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Valencia NutritionBOM:542910 -13.45%51 PB Ratio is 1.76 as of Aug. 08, 2026, which is 66% below its 10-year median of 5.20. GuruFocus rates BOM:542910 with a GF Score™ of 51/100 and a GF Value™ of ₹65.92 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 1,228 Biotechnology companies, Valencia Nutrition ranks better than 62.3% on this metric.
Valencia Nutrition Ltd stock PB Ratio (=1.92) is close to 10-year low of 1.88.
The historical rank and industry rank for Valencia Nutrition's PB Ratio or its related term are showing as below:
BOM:542910'
s PB Ratio Range Over the Past 10 Years
Min: 1.76 Med: 5.2 Max: 40.56
Current: 1.76
During the past 10 years, Valencia Nutrition's highest PB Ratio was 40.56. The lowest was 1.76. And the median was 5.20.
BOM:542910's PB Ratio is ranked better than 62.3% of 1228
companies
in the Biotechnology industry
Industry Median: 2.905
vs BOM:542910: 1.76
During the past 12 months, Valencia Nutrition's average Book Value Per Share Growth Rate was 13.70% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Valencia Nutrition was 229.70% per year. The lowest was -3.00% per year. And the median was 4.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Valencia Nutrition PB Ratio Related Terms
Valencia Nutrition PB Ratio Historical Data
* Premium members only.
The historical data trend for Valencia Nutrition's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542910 vs VRTX, REGN, RVMD: PB Ratio Comparison
For the Biotechnology subindustry, Valencia Nutrition's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Valencia Nutrition PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Valencia Nutrition's PB Ratio distribution charts can be found below:
* The bar in red indicates where Valencia Nutrition's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Valencia Nutrition (BOM:542910) has a PB Ratio of 1.76 as of Aug. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Valencia Nutrition and its competitors. This is 66% below median its historical median of 5.20. Over the past decade, Valencia Nutrition's PB Ratio has ranged from 1.76 to 40.56. According to the industry distribution chart, Valencia Nutrition ranks #463 out of 1228 companies in the Biotechnology industry, placing it in the top 37.7%.
Is Valencia Nutrition's PB Ratio too high?
Valencia Nutrition's current PB Ratio of 1.76 is 66% below median its 10-year median of 5.20. Over the past 10 years, this metric has ranged from a low of 1.76 to a high of 40.56. The Biotechnology industry median PB Ratio is 2.91. Valencia Nutrition's value of 1.76 is 39.4% below this industry median. Based on the distribution chart, Valencia Nutrition ranks #463 out of 1228 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Valencia Nutrition has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Valencia Nutrition's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Valencia Nutrition ranks #463 out of 1228 companies for PB Ratio. This puts Valencia Nutrition in the upper half of its industry. The industry median PB Ratio is 2.91. Valencia Nutrition's value of 1.76 is 39.4% below this benchmark. Historically, Valencia Nutrition's own PB Ratio has ranged from 1.76 to 40.56 over the past decade. While the company's 10-year median is 5.20 vs. the industry median of 2.91, Valencia Nutrition has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.91, based on 1,228 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Valencia Nutrition's current PB Ratio of 1.76 is 39.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Valencia Nutrition and its competitors. For the Biotechnology industry, the median PB Ratio is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Valencia Nutrition's current PB Ratio is 1.76, which is 66% below median its own 10-year median of 5.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valencia Nutrition stock overvalued right now?
Based on GuruFocus' analysis, Valencia Nutrition (BOM:542910) is currently considered Possible Value Trap. The stock's GF Value™ is ₹65.92, compared to a current price of ₹43.10 — trading 34.6% below its estimated fair value. The current PB Ratio is 1.76, which is 66% below median its 10-year median of 5.20 and 39.4% below the Biotechnology industry median of 2.91. Valencia Nutrition's overall GF Score™ is 51/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Valencia Nutrition (BOM:542910), the current PB Ratio is 1.76 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Valencia Nutrition (BOM:542910) Overvalued in 2026?
Based on GuruFocus' analysis, Valencia Nutrition stock appears to be undervalued.
The current stock price of ₹43.10 is trading 34.6% below its estimated GF Value™ of ₹65.92.
GuruFocus considers Valencia Nutrition to be Possible Value Trap.
Key valuation signals for BOM:542910:
PB Ratio: 1.76 (66% below median its 10-year median of 5.20)
GF Value™: ₹65.92 vs. price of ₹43.10 (34.6% below fair value)
Industry Position: 39.4% below the Biotechnology median (#463 of 1228)
No single metric tells the full story. See the BOM:542910 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Valencia Nutrition Ltd is a biotechnology company engaged in researching, developing, manufacturing, selling, and distributing nutraceutical products such as multi-nutrient functional beverages to prevent and/or manage lifestyle-related diseases. The company's products include Bounce Superdrinks and VitaMe Enriched Beverages.
51GF Score
Get the complete analysis for BOM:542910
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542910 has been successfully added to your 
